Sharkey, Howes & Javer - Glaxosmithkline PLC ADRF ownership

Glaxosmithkline PLC ADRF's ticker is and the CUSIP is 3733W105. A total of 2 filers reported holding Glaxosmithkline PLC ADRF in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Sharkey, Howes & Javer ownership history of Glaxosmithkline PLC ADRF
ValueSharesWeighting
Q3 2016$35,0000.0%8000.0%0.02%
-4.5%
Q2 2016$35,000
+9.4%
8000.0%0.02%
-4.3%
Q1 2016$32,0000.0%8000.0%0.02%
+4.5%
Q4 2015$32,0008000.02%
Other shareholders
Glaxosmithkline PLC ADRF shareholders Q4 2015
NameSharesValueWeighting ↓
Fusion Investment Group, LLC 4,991$202,0000.54%
Sharkey, Howes & Javer 800$32,0000.02%
View complete list of Glaxosmithkline PLC ADRF shareholders